Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Specificity of Antibodies Directed against Env Protein of Human Endogenous Retroviruses in Patients with Germ Cell Tumors

Marlies Sauter, Klaus Roemer, Barbara Best, Matthias Afting, Stefanie Schommer, Gerhard Seitz, Michael Hartmann and Nikolaus Mueller-Lantzsch
Marlies Sauter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Roemer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Best
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Afting
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefanie Schommer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Seitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hartmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaus Mueller-Lantzsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published October 1996
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We report here that 85% of the patients with germ cell tumors (GCTs) produce antibodies directed against Env protein of human endogenous retroviruses. Individuals that received antitumor treatment showed a decrease with time in their antibody titers. Importantly, of the rare cases of non-GCT individuals with Env-antibodies (n = 15, 0.8%), none produced antibodies directed against the transmembrane domain (TM), whereas all tested Env-positive GCT patients (n = 49) generated such antibodies at high titers. TM is required for Env to be expressed at the cell surface. Thus, anti-TM antibodies constitute highly specific markers for GCT and may hint at a function of Env during tumorigenesis.

Footnotes

  • ↵1 Supported by the Deutsche Forschungsgemeinschaft (Grant Mu 452/-1) and the Commission of the European Union (GENE-CT93-0019).

  • ↵2 To whom requests for reprints should be addressed. Phone: 49-06841/163931; Fax: 49-06841/163980.

  • Received July 1, 1996.
  • Accepted August 14, 1996.
  • ©1996 American Association for Cancer Research.
PreviousNext
Back to top
October 1996
Volume 56, Issue 19
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Specificity of Antibodies Directed against Env Protein of Human Endogenous Retroviruses in Patients with Germ Cell Tumors
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Specificity of Antibodies Directed against Env Protein of Human Endogenous Retroviruses in Patients with Germ Cell Tumors
Marlies Sauter, Klaus Roemer, Barbara Best, Matthias Afting, Stefanie Schommer, Gerhard Seitz, Michael Hartmann and Nikolaus Mueller-Lantzsch
Cancer Res October 1 1996 (56) (19) 4362-4365;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Specificity of Antibodies Directed against Env Protein of Human Endogenous Retroviruses in Patients with Germ Cell Tumors
Marlies Sauter, Klaus Roemer, Barbara Best, Matthias Afting, Stefanie Schommer, Gerhard Seitz, Michael Hartmann and Nikolaus Mueller-Lantzsch
Cancer Res October 1 1996 (56) (19) 4362-4365;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Advances in Brief

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
  • Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy
Show more Advances in Brief

Articles

  • BCL-2 Gene Family and the Regulation of Programmed Cell Death
  • Role of TCL1 and ALL1 in Human Leukemias and Development
  • Introduction of H. Robert Horvitz
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement